2 results
6-K
EX-99.1
CALT
Calliditas Therapeutics AB
28 Apr 23
Current report (foreign)
4:05pm
No treatment Screening Treatment Follow up ~50 Patients ≤ 28 Days Tumour accessible for tissue biopsy Positive CAF level (de-fined as CAFs level in tumours
6-K
EX-99.1
CALT
Calliditas Therapeutics AB
29 Apr 22
Current report (foreign)
4:02pm
- fined as CAFs level in tumours ≥5%) No treatment Randomized, Double Blind All Enrolled Patients Tumour Biopsy 9 weeks (±1 week) Pembrolizumab 200mg IV
- Prev
- 1
- Next